Nicole Degraff
Physician Assistant · Battle Creek, MINPI 1891815411
Payments from drug & device makers
Across 117 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$278
- GSK$276
- Novo Nordisk$267
- Boehringer Ingelheim$237
- Mylan Specialty L.p.$161
- Lilly USA, LLC$153
- plus $875 from 19 others
What the payments were for
- Food & beverage$2,15396%
- Education$944%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $278 |
| GSK | 18 | $276 |
| Novo Nordisk | 14 | $267 |
| Boehringer Ingelheim | 12 | $237 |
| Mylan Specialty L.p. | 7 | $161 |
| Lilly USA, LLC | 8 | $153 |
| Pfizer | 6 | $131 |
| Bayer | 7 | $104 |
| Astellas Pharma US Inc | 1 | $94 |
| Johnson & Johnson | 5 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Exact Sciences | 3 | $63 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $57 |
| Lundbeck LLC | 2 | $46 |
| Dexcom, Inc. | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Neurelis, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Merck | 1 | $20 |
| Insulet Corporation | 1 | $20 |
| Amgen | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $18 |
| AstraZeneca | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,247 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 63 | $84,954 |
| MounjaroTirzepatide | 37 | $62,951 |
| JardianceEmpagliflozin | 50 | $58,728 |
| EliquisApixaban | 35 | $45,650 |
| XareltoRivaroxaban | 37 | $38,655 |
| FarxigaDapagliflozin Propanediol | 28 | $36,341 |
| TrulicityDulaglutide | 25 | $34,808 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $33,762 |
| JanuviaSitagliptin Phosphate | 30 | $29,157 |
| EntrestoSacubitril/Valsartan | 13 | $29,070 |
| VraylarCariprazine Hcl | 20 | $29,023 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $26,445 |
| Humalog Kwikpen U-200Insulin Lispro | 26 | $22,405 |
| Tresiba Flextouch U-100Insulin Degludec | 37 | $19,171 |
| RybelsusSemaglutide | 11 | $15,199 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $267 | $100,15374 claims |
| Lilly USA, LLCMounjaro, Trulicity | $153 | $97,75962 claims |
| Boehringer IngelheimJardiance | $237 | $58,72850 claims |
| AbbVieVraylar, Linzess, Fetzima | $278 | $49,34348 claims |
| PfizerEliquis, Prempro | $131 | $49,15349 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $276 | $47,91749 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $14 | $47,30555 claims |
| Johnson & JohnsonXarelto | $79 | $38,65537 claims |
| MerckJanuvia, Steglatro | $20 | $33,34142 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $21 | $7,52014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Battle Creek
- Kirstin TymkewBattle Creek$23K
- Julia SwaffordBattle Creek$16K
- Maureen GradyBattle Creek$14K
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.